stage IV lymphoepithelioma of the oropharynx
Showing 1 - 25 of >10,000
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the
Active, not recruiting
- Human Papilloma Virus Infection
- +3 more
- paclitaxel albumin-stabilized nanoparticle formulation
- +8 more
-
Chicago, IllinoisUniversity of Chicago
Mar 2, 2022
Malignant Tumor of Oropharynx Stage III, Malignant Tumor of Larynx Stage III, Malignant Tumor of Hypopharynx Stage III Trial in
Recruiting
- Malignant Neoplasm of Oropharynx Stage III
- +7 more
- Escalated Dose
- Standard Dose
-
Kolkata, West Bengal, IndiaTata Medical Centre
Dec 2, 2021
Head Neck Cancer Trial in France (cisplatin, docetaxel, fluorouracil)
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Head Neck Cancer Trial in Nashville (biologic sample preservation procedure, medical chart review)
Recruiting
- Head and Neck Cancer
- biologic sample preservation procedure
- medical chart review
-
Nashville, Tennessee
- +3 more
Oct 28, 2022
Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma
Completed
- Stage II Lymphoepithelioma of the Nasopharynx
- +5 more
- docetaxel
- +5 more
-
Stanford, CaliforniaStanford University Hospitals and Clinics
Mar 10, 2021
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- cetuximab
- +3 more
-
Newark, New JerseyNew Jersey Medical School
Apr 19, 2021
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,
Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell
Completed
- Stage IV Squamous Cell Carcinoma of the Hypopharynx
- +3 more
-
Boston, Massachusetts
- +1 more
Feb 11, 2021
Anorexia, Cachexia, Head Neck Cancer Trial in Winston-Salem (megestrol acetate, quality-of-life assessment)
Completed
- Anorexia
- +3 more
- megestrol acetate
- quality-of-life assessment
-
Winston-Salem, North CarolinaComprehensive Cancer Center at Wake Forest University
Sep 7, 2021
Oral Cancer, Oropharynx Cancer, Hypopharynx Cancer Trial in Vandoeuvre les Nancy, Villejuif (IMRT 75 Gy, Conventional
Completed
- Oral Cancer
- +2 more
- IMRT 75 Gy
- +2 more
-
Vandoeuvre les Nancy, France
- +1 more
Apr 14, 2020
HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer Trial in Milwaukee (HB-201 IT, HB-201 IV)
Recruiting
- HPV 16+ Confirmed Oropharynx Cancer and Cervical Cancer
- HB-201 IT
- HB-201 IV
-
Milwaukee, WisconsinFroedtert Hospital and the Medical College of Wisconsin
Jul 28, 2022
Oropharynx Cancer, Tonsil Cancer, Base of the Tongue Tumor Trial (Transoral Ultrasound, Transcervical Ultrasound)
Not yet recruiting
- Oropharynx Cancer
- +7 more
- Transoral Ultrasound
- Transcervical Ultrasound
- (no location specified)
Jan 31, 2023
Squamous Cell Carcinoma Trial in Philadelphia (fluorine F18 EF5, immunohistochemistry staining method, biopsy)
Completed
- Squamous Cell Carcinoma
- fluorine F18 EF5
- +3 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 23, 2020
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- erlotinib hydrochloride
- +10 more
-
Cleveland, OhioCase Medical Center, University Hospitals Seidman Cancer Center,
May 6, 2020
Squamous Cell Carcinoma, Oropharynx Cancer, Head Neck Cancer Trial in Houston (SAR444245, Cemiplimab)
Not yet recruiting
- Squamous Cell Carcinoma
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 7, 2022
Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally
Recruiting
- Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
- +5 more
- Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
- Pembrolizumab
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
ctDNA and/or HPV DNA in High-risk Locally-advanced Head and Neck
Active, not recruiting
- Cancer
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 7, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +57 more
- placebo
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 18, 2020
Head Neck Cancer, Mucositis Oral, Radiation Toxicity Trial in San Francisco (sargramostim, oral salt and soda mouthwash)
Completed
- Head and Neck Cancer
- +3 more
- sargramostim
- oral salt and soda mouthwash
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 9, 2021
Head Neck Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous
Completed
- Head and Neck Cancer
- +19 more
- lapatinib ditosylate
- capecitabine
-
Philadelphia, PennsylvaniaAbramson Cancer Center of The University of Pennsylvania
Mar 6, 2020
Head Neck Cancer Trial in United States (fruit and vegetable extracts, )
Completed
- Head and Neck Cancer
- fruit and vegetable extracts
- placebo
-
Santa Rosa, California
- +27 more
Sep 7, 2021